MannKind Corporation


Company Update (NASDAQ:MNKD): MannKind Corporation Reports 2016 Second Quarter Financial Results

MannKind Corporation (NASDAQ:MNKD) reported financial results for the second quarter and the six months ended June 30, 2016. For the second quarter ended June …

Monday Morning’s Market Insights: LinkedIn Corp (LNKD), Eleven Biotherapeutics Inc (EBIO), MannKind Corporation (MNKD), Sunesis Pharmaceuticals, Inc. (SNSS)

LinkedIn Corp (NYSE:LNKD) is up a whopping 48% after Microsoft agreed to buy the company for $26.2 billion in cash.

Company Update (NASDAQ:MNKD): MannKind Corporation Announces Late-Breaking Data Reinforcing Faster Onset and Shorter Duration of Action Compared to Mealtime Insulins

MannKind Corporation (NASDAQ:MNKD) announced results of two late-breaking posters and four additional analyses of Afrezza® (insulin human) Inhalation Powder, including three posters demonstrating a …

Stock Update (NASDAQ:MNKD): MannKind Corporation Announces Collaboration with JDRF

MannKind Corporation (NASDAQ:MNKD) announced that it has entered into a collaboration agreement with JDRF (formerly known as Juvenile Diabetes Research Foundation), the leading global …

Tuesday’s Market Insights: SolarCity Corp (SCTY), MannKind Corporation (MNKD), Alexza Pharmaceuticals, Inc. (ALXA) and NewLink Genetics Corp (NLNK)

SolarCity Corp (NASDAQ:SCTY) is falling 20% in pre-market trading after the company reported Q1:16 earnings yesterday after market close. The company posted revenues …

Stock Update (NASDAQ:MNKD): MannKind Corporation Announces Pricing of Registered Direct Public Offering of Common Stock and Warrants

MannKind Corporation (NASDAQ:MNKD) announced the pricing of a registered direct public offering of up to 48,543,692 shares of common stock and warrants to …

Stock Update (NASDAQ:MNKD): MannKind Corporation Reports 2016 First Quarter Financial Results

MannKind Corporation (NASDAQ:MNKD) reported financial results for the first quarter ended March 31, 2016. For the first quarter of 2016, total operating expenses were …

Biotech’s Week Ahead: MannKind Corporation (MNKD), Allergan plc Ordinary Shares (AGN), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), and Horizon Pharma PLC (HZNP)

It’s an eventful week ahead for pharmaceutical companies MannKind Corporation (NASDAQ:MNKD), Allergan plc Ordinary Shares (NYSE:AGN), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), and Horizon Pharma PLC …

Analysts Chime In on Two Biotech Stocks: MannKind Corporation (MNKD), Dynavax Technologies Corporation (DVAX)

Healthcare analysts give their two cents on recent updates by MannKind Corporation (NASDAQ:MNKD) and Dynavax Technologies Corporation (NASDAQ:DVAX). One analyst remains on the …

Stock Update (NASDAQ:MNKD): MannKind Corporation Expands Commercial Capabilities With Two New Hires

MannKind Corporation (NASDAQ:MNKD) announced two senior appointments to its commercial organization.  Joining the Company are Joseph Saldanha as Vice President of Marketing and Agustin …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts